Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FTGRJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,794
Award facts
- Contract value 100% obligated
- $24,794.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,794.40 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on June 24, 2025, with an ultimate completion date of June 25, 2025. This firm fixed price delivery order represents a non-competitive procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a specialty pharmaceutical used to treat various inflammatory and allergic conditions, reflecting the Defense Logistics Agency's critical role in ensuring pharmaceutical availability across military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a comprehensive federal contract portfolio supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's Indefinite Delivery Contract with DLA Troop Support Medical serves as a flexible procurement vehicle enabling rapid fulfillment of pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. This delivery order exemplifies AmerisourceBergen's operational capacity to support military medical supply chains through competitively awarded contracts with firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DB25FTGRJ?
SPE2DB25FTGRJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 24, 2025.
How much is contract SPE2DB25FTGRJ worth?
The government has obligated $24,794 on SPE2DB25FTGRJ.
Is contract SPE2DB25FTGRJ an order under another contract?
Yes. SPE2DB25FTGRJ is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB25FTGRJ competed?
The extent of competition for SPE2DB25FTGRJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award